Publications by authors named "Y Tessier"

Claim this Profile
O
Opportunities for More Tailored Approaches to Genotoxicity Testing and Carcinogenicity Strategy for Oligonucleotide Therapeutics: Outcome of an Industry Survey.
Joel D Parry, Tod A Harper, Patrik Andersson, Joanne M Elloway, Natalie S Holman, Yann Tessier

Nucleic Acid Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Angers CT Score is a Risk Factor for the Failure of the Conservative Management of Adhesive Small Bowel Obstruction: A Prospective Observational Multicentric Study.
Anita Paisant, Jeanne Burgmaier, Paul Calame, Mélanie Loison, Sébastien Molière, Yann Tessier

World J Surg· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet Activation by Antisense Oligonucleotides (ASOs) in the Göttingen Minipig, including an Evaluation of Glycoprotein VI (GPVI) and Platelet Factor 4 (PF4) Ontogeny.
Allan Valenzuela, Miriam Ayuso, Laura Buyssens, Chloé Bars, Chris Van Ginneken, Yann Tessier

Pharmaceutics· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety Testing of an Antisense Oligonucleotide Intended for Pediatric Indications in the Juvenile Göttingen Minipig, including an Evaluation of the Ontogeny of Key Nucleases.
Allan Valenzuela, Claire Tardiveau, Miriam Ayuso, Laura Buyssens, Chloe Bars, Yann Tessier

Pharmaceutics· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tissue Distribution, and Metabolism of LNA-Containing Antisense Oligonucleotides in Rats.
Fernando Romero-Palomo, Matthias Festag, Barbara Lenz, Simone Schadt, Andreas Brink, Yann Tessier

Toxicol Pathol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis